View on Pubmed.gov 28469141 | View on doi.org 10.1038/s41598-...
Serum MicroRNAs Reflect Injury Severity in a Large Animal Model of Thoracic Spinal Cord Injury.
- International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, British Columbia, Canada.
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- Translational Genomics, Phoenix, Arizona, United States of America.
- Acorda Therapeutics, Ardsley, New York, United States of America.
- International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, British Columbia, Canada. brian.kwon@ubc.ca.
- Vancouver Spine Surgery Institute, Department of Orthopedics, University of British Columbia, Vancouver, British Columbia, Canada. brian.kwon@ubc.ca.
Abstract
Therapeutic development for spinal cord injury is hindered by the difficulty in conducting clinical trials, which to date have relied solely on functional outcome measures for patient enrollment, stratification, and evaluation. Biological biomarkers that accurately classify injury severity and predict neurologic outcome would represent a paradigm shift in the way spinal cord injury clinical trials could be conducted. MicroRNAs have emerged as attractive biomarker candidates due to their stability in biological fluids, their phylogenetic similarities, and their tissue specificity. Here we characterized a porcine model of spinal cord injury using a combined behavioural, histological, and molecular approach. We performed next-generation sequencing on microRNAs in serum samples collected before injury and then at 1, 3, and 5 days post injury. We identified 58, 21, 9, and 7 altered miRNA after severe, moderate, and mild spinal cord injury, and SHAM surgery, respectively. These data were combined with behavioural and histological analysis. Overall miRNA expression at 1 and 3 days post injury strongly correlates with outcome measures at 12 weeks post injury. The data presented here indicate that serum miRNAs are promising candidates as biomarkers for the evaluation of injury severity for spinal cord injury or other forms of traumatic, acute, neurologic injury.
References
Spinal Cord. 2014 Jun;52(6):428-33
J Neurotrauma. 2012 May 20;29(8):1626-37
Physiol Genomics. 2005 Aug 11;22(3):368-81
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1826-34
Cited by 57 citations (total)
Journal Article Review
Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review.
Electronic publication date December 21, 2023
Jiawei Wang [...] Chunfang Wang et al.
The prevention, treatment, and rehabilitation of spinal cord injury (SCI) have always posed significant medical challenges. After mechanical injury, disturbances...
Journal Article
MiR-33-5p alleviates spinal cord injury in rats and protects PC12 cells from lipopolysaccharide-induced apoptosis.
Electronic publication date January 13, 2023
Zhe Li [...] Yuan-Shi Zhang et al.
MicroRNAs (miRNAs) exert critical effects in spinal cord injury (SCI). The miR-33-5p level is found to be lower in rats...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •